Patent Docs

European Biotech Patent Law Webinar

D Young & Co will be offering its next European biotech patent law update on June 25, 2024.  The webinar will be offered at three times:  9:00 am, noon, and 5:00 pm (BST).  D Young & Co European Patent Attorneys Simon O'Brien and Nathaniel Wand will discuss the latest European biotech patent case law developments, including the following:

T 910/21: New purpose of treating the same disease
T 209/22: Novelty-sufficiency squeeze based on clinical trial
T 1255/21: Lack of inventive step in view of clinical trial protocol
T 1252/20: The definition of "substance or composition" in medical use claims
T 1920/21: Limits to "diagnostic method" exclusion

While there is no fee to participate, attendees must register in advance.  Those wishing to register can do so here.

ACI Summit for Women Leaders in IP Law

The American Conference Institute will be holding its 4th Annual Summit for Women Leaders in IP Law on June 25-26, 2024 at the National Union Building in Washington D.C.  The Summit will enable women in Intellectual Property roles to come together to explore industry trends and important factors impacting today's women IP leaders and practitioners.  This year's co-chairs are Vanessa Bailey, Head of Patent Policy at Amazon and Adrianna S. Luedke, Director and Associate General Counsel at Lockheed Martin Corp.

In past conferences, attendees have been able to learn to advance and thrive in the intellectual property field, to benefit professionally and personally from the advice and storytelling of other women in the industry, and meet with industry counterparts and expand their network with a focus on camaraderie.

This year's program highlights include battling with DEI backlash, tackling the AI-IP conundrum, IP litigation spotlight, secrets from the boardroom and key strategies for safeguarding.  Here will also be concurrent "Bids of Feather" roundtables on mentoring, personal branding, and the CHIPS Act.

Valencia Martin-Wallace, Deputy Commissioner for Patents, U.S. PTO and Jennifer Dixon, Assistant Chief, Special Counsel for Policy and Intellectual Property, Antitrust Division, U.S. Department of Justice will be the Keynote Speakers.

The brochure, agenda, and registration information can be found here.  The fee for the conference is $2,095.  ACI can be contacted by e-mail at [email protected] and by telephone at 1-888-224-2480.

Patent Docs readers can save 10% by using promo code: D10-999-PD24.

ACI Summit on Biosimilars

American Conference Institute (ACI) will be holding is 15th Annual Summit on Biosimilars & Innovator Biologics: Legal, Regulatory, and Commercial Strategies for the Innovator and Biosimilars Marketplace on June 20-21, 2024 at the New York City Bar Association.  Conference Co-Chairs are Deidre Parsons, Senior Director, Public Policy & Governmental Relations, Alnylam Therapeutics; Harshika Sarbajna, Vice President Commercial and Head Global, Alvotech; and Paki Banky, Director, Senior IP Counsel, IP Lead Cell and Gene at Novartis.

Conference attendees will hear from Administrative Patent Judges the Honorable Jacqueline Bonilla, Deputy Chief; the Honorable Linda Horner; and the Honorable Grace Obermann, as well as Supervisory Patent Examiner Vanessa Ford and Laurel Goldberg, Regulatory Counsel, CDER, Food and Drug Administration.

ACI faculty will offer presentations on the Biden Administration's initiatives on drugs and pricing strategies; an investors' roundtable on biosimilar valuation; the impact and insights for the future from Humira biosimilar launches; IPRs and policies and practices before the PTAB; and diversity, equity and inclusion in this industry, among others.

An agenda for the conference can be found here, including a complete brochure for this conference, detailed descriptions of conference sessions, list of speakers, and registration form.  The registration fee is $2,395 for registration and payment by Mary 24, 2024; and $2,595 for payment by June 20th.  Patent Docs readers are entitled to a 10% discount off registration using discount code D10-999-PD24.  Those interested in registering for the conference can do so here, by emailing [email protected], or by calling 1-888-224-2480.

Patent Docs is a media partner of ACI's 15th Annual Summit on Biosimilars.

ACI Advanced Summit on Life Sciences Patents

American Conference Institute (ACI) will be holding its 22nd Advanced Summit on Life Sciences May 29-30, 2024 at the Fairfield Inn & Suites Manhattan Times Square South, New York, NY.

This year's conference co-chairs include MJ Edwards (Senior Associate General Counsel, Patent Prosecution Team Lead, Gilead Sciences Inc.), Nicole Woods (Vice President, Assistant General Patent Counsel, Eli Lilly and Company), and Mercedes Meyer (Partner, Banner Witcoff LLP).

This year's event highlights deep dives into the best regulatory and IP strategies for protecting digital health therapies and inventions created with the assistance of AI and machine learning, establishing sound and successful protocols to procure and enforce life sciences patents in the U.S. and internationally and much more.

An agenda for the conference can be found here, including a complete brochure for this conference, detailed descriptions of conference sessions, list of speakers, and registration form.  The registration fee for the conference is $2,595.  Patent Docs readers are entitled to a 10% discount off of registration using discount code D10-999-PD24.  Those interested in registering for the conference can do so here, by e-mailing [email protected], or by calling 1-888-224-2480.

Patent Docs is a media partner of ACI's 22nd Advanced Summit on Life Sciences.

ACI Paragraph IV Disputes Conference

The American Conference Institute (ACI) will be presenting its 20th Annual Paragraph IV Disputes Conference on April 25-26, 2024 in New York City.  As in the past, this curated program will not only address "hot" topics but also will put the issues within the context of pre-suit considerations, case filings, final adjudication, and every step in between.

This year's conference co-chairs include Andrei Iancu (Partner, Sullivan & Cromwell LLP and former Director of the USPTO), Brian Malkin (Associate General Counsel, Teva Pharmaceuticals), and Mira Mulvaney (Assistant General Patent Counsel, IP Litigation, Eli Lilly & Company).

The conference will be honored by the presence of the Honorable Pauline Newman and former Chief Judge the Honorable Randall Rader from the Federal Circuit, as well as the Honorable Judge Stanley R. Chester from the District Court of New Jersey and Magistrate judge the Honorable Tonianne J. Bongiovanni and the Honorable Sherry R. Fallon.

Joining participants will be Hatch-Waxman litigators, in-house advisers, Chief IP and senior IP/Patent counsel from leading brand name and generic pharmaceutical companies, who will discuss, debate, and analyze the latest trends, decisions, legislative and regulatory advancements affecting Hatch-Waxman litigation.

The brochure, agenda, and registration information can be found here.  ACI can be contacted by e-mail at  [email protected] and by telephone at 1-888-224-2480.

Patent Docs readers can save 10% by using promo code: D10-999-PD24.

MBHB Webinar on Top Patent Law Stories of 2023

McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar on the "Top Patent Law Stories of 2023" on January 23, 2024 from 10:00 am to 11:15 am (CT).  Since 2007, the Patent Docs weblog has presented an annual, end-of-the-year review of the top stories in patent law.  In this presentation, Patent Docs co-authors Donald Zuhn, Kevin Noonan, and Michael Borella will take a look back at the top patent stories of 2023, many of which will likely impact patent applicants and practitioners in the coming year.

While there is no fee to participate, attendees must register in advance.  Those wishing to register can do so here.  CLE credit is pending for the states of California, Illinois, New Jersey, New York, North Carolina, and Virginia.

IPO Webinar: 2023 PTAB Year in Review

The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "2023 PTAB Year in Review," on January 16, 2024 from 1:00 pm to 2:00 pm (ET).  Sendil Devadas of Corteva Agriscience; Joshua Goldberg of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; and Kassandra Officer of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will discuss some of the most significant developments in PTAB practice in 2023 and how those developments will impact future cases, and discuss important decisions promulgated last year, including several designated precedential, as well as court treatment of PTAB decisions with implications for PTAB practice.

The registration fee for the webinar is $150 for non-members or free for IPO members (government and academic rates are available upon request).  Those interested in attending the webinar should register here.

Webinar on Unified Patent Court from a U.S. Perspective

IPWatchdog and Bardehle Pagenberg will be offering a webinar entitled "The State of Play at the UPC from a US-Perspective -- Insights from a UPC Litigator" on January 17, 2024 at 12:00 pm (ET).  Gene Quinn of IPWatchdog, Inc. and Tobias Wuttke of Bardehle Pagenberg will discuss Unified Patent Court (UPC) developments from a U.S. perspective and how U.S. companies should adjust their enforcement and defense strategies in light of the emerging legal framework, and also cover how UPC litigation may complement U.S. patent enforcement as well as U.S. patent defense strategies.  The webinar will address the following topics:

• Insights on how the UPC is operating, what the UPC time schedules and case management look like, and how internal workflows should be optimized
• Clarity on the most relevant case law handed down by the UPC
• Ways to improve defensive and offensive patent strategies involving this new forum
• A better understanding of what the UPC really means from a U.S. perspective

There is no registration fee for this webinar.  However, those interested in registering for the webinar, should do so here.

IPO Webinar: 2023 Case Law Year in Review

The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "2023 Case Law Year in Review," on January 17, 2024 from 1:00 pm to 2:00 pm (ET).  Paul Berghoff of McDonnell Boehnen Hulbert & Berghoff LLP, Gregory Castanias of Jones Day, and Wendy Larson of Pirkey Barber will attempt to distill down the past year's major decisions from the Supreme Court, Federal Circuit, PTAB, and TTAB, and discuss the ones that will affect IP practitioners in 2024 and beyond.

The registration fee for the webinar is $150 for non-members or free for IPO members (government and academic rates are available upon request).  Those interested in attending the webinar should register here.

Webinar on Implementing Regulations of Chinese Patent Law

Schwegman Lundberg & Woessner will be offering a SLW Institute webinar entitled "Top 5 Changes in Chinese Patent Practice Based on the Amended Implementing Regulations of the Patent Law" on January 18, 2024 at 1:00 pm (CT).  Aaron Wininger of Schwegman Lundberg & Woessner will discuss the long-awaited amended Implementing Regulations of the Patent Law released by China's State Council in December 2023 that will take effect on January 20, 2024, and discuss the changes that have been made and how they will impact Chinese patent practice going forward.

While there is no cost to participate in the program, those interested in attending the webinar can register here.

ACI Passport to Proficiency on Essentials of Hatch-Waxman and BPCIA

The American Conference Institute (ACI) will be presenting its 3rd Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA as part of its VIRTUAL proficiency series on October 10-26, 2023.  The course provides a primer on IP basics and regulatory fundamentals relating to small molecules and biologics for practitioners representing brand name, generic, and biopharma drugs.

The three week virtual course is set out in three topic areas.  Week 1 (sessions on October 10th and 12th) will set forth the regulatory foundation of pharmaceutical patent protection and regulatory approval.  These sessions will discuss the interplay of the FDA and PTO; pre-commercialization concerns; the links between the drug approval process at FDA and patenting before the USPTO; and discuss the intricacies of the Orange Book.

Week 2 (October 17th and 19th) explore the Hatch-Waxman and BPCIA regulatory frameworks, including the Hatch-Waxman landscape; Paragraph IV dispute and litigation; biosimilars, the BPCIA and aBLA; participation in the "patent dance" set out in the BPCIA statutory regime; and the Purple Book, the biologics/biosimilar counterpart of the Orange Book, as well as the distinctions between the two.

Week 3 (October 24th and 26th) will focus on bioequivalence, exclusivity, extensions, and exceptions.  These sessions will discuss bioequivalcency, interchangeability, and the distinctions between the two; the 180-day exclusivity provided to first generic filers under Hatch-Waxman; non-patent/regulatory exclusivities; exploring the safe harbor for research under 35 U.S.C. § 271(e)(1); and obtaining patent term extensions.

Instructors include Li Feng/Finnegan, Henderson, Farabow, Garrett, and Dunner; Rachel L. Pernic Waldron/Rakoczy Molino Mazzoci Siwik; David B. Abramowitz/Locke Lord; Michael A. Davitz/Leason Ellis; Daniel Klein/Groombridge, Wu, Baughman & Stone; Frederick Ball/Duane Morris; Dov Grossman/Williams & Connolly; Keeto Sabharwal/Husch Blackwell; Daniel P. Margolis/Allen & Overy; Bryan Vogel/Robins Kaplan; April Weisbruch/McDermott Will & Emery; Kyle Musgrove/Parker Poe Adams & Bernstein; Gary Vernon/Hogan Lovells; Mureen Rurka/Winston & Strawn; Christina Markus/King & Spaulding; Jordan Markham/Steptoe & Johnson; Christopher Noyes/WilmerHale; Brian Burgess/Goodwin Proctor; Lara E. FitzSimmons/ Rakoczy Molino Mazzoci Siwik; David Ffazier/Latham & Watkins; Rob Vrna/Young Conaway Stargatt & Taylor; Fabian Koenigbauer/Ice Miller; and Matthew Murphy/Axinn, Veltrop & Harkrider.

The brochure, agenda, and registration information can be found here.  The registration fee for the program, including all modules, is $1,795 if registration and payment is received by September 22, 2023 and $1,895 if registration and payment is received by October 10th.  ACI can be contacted by e-mail at [email protected] and by telephone at 1-888-224-2480.

Patent Docs readers can save 10% by using promo code: D10-999-PD24.

Webinar on Using Sequence Data to Strengthen Biologics Patent Claims and Applications

IPWatchdog and CAS will be offering a webinar entitled "Use Sequence Data to Strengthen Biologics Patent Claims and Applications" on August 29, 2023 at 12:00 pm (ET).  Gene Quinn of IPWatchdog, Inc. will moderate a panel consisting of Lisa L. Mueller of Casimir Jones, S.C.; Raymond N. Russell of Tarolli, Sundheim, Covell & Tummino LLP; and Anne Marie Clark of CAS IP Services, who will discuss challenges and ways to use quality sequence data more effectively to build stronger biologics patent claims and applications.  The panel will address the following topics:

• Avoiding claims pitfalls with competent sequence search strategies
• Insights to ensure biologics claims meet novelty and obviousness
• How recent court rulings are affecting written claims
• When and why to make go/no-go application decisions
• Amending claims as new research data arises to capture IP value

There is no registration fee for this webinar.  However, those interested in registering for the webinar, should do so here.

USPTO to Hold TC 2600 Customer Partnership Meeting

The U.S. Patent and Trademark Office will be holding a virtual customer partnership meeting of Technology Center 2600 from 1:00 pm to 3:00 pm (ET) on July 25, 2023.  The meeting will include the following sessions:

• "Clarity of the Record" presentation
• Small-Group Exercises -- breakout sessions emphasizing presentation points and application of ideas
• Groups Report Out + Collaborative Discussion -- large group discussion with report out

A complete agenda for the meeting can be found here.  Additional information regarding the customer partnership meeting, including how to register for the meeting, can be found here.

IPO Webinar on Mid-Year Case Law Review

The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "2023 Mid-Year Case Law Review," on July 26, 2023 from 1:00 pm to 2:00 pm (ET).  Paul Berghoff of McDonnell Boehnen Hulbert & Berghoff LLP, Gregory Castanias of Jones Day, and Wendy Larson of Pirkey Barber will cover recent developments in case law over the past six months, including notable decisions issued by the lower tribunals in the first half of the year.  Among the decisions to be covered will be Amgen v. Sanofi, where the Supreme Court addressed the enablement requirement for patent claims directed to antibodies.

There is no registration fee for the webinar.  However, those interested in attending the webinar should register here.